ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "In Conversation: Elisabeth Bjork "
Episode Synopsis
Elisabeth Bjork heads up AstraZeneca’s late-stage development within cardiovascular, renal and metabolic diseases (CVRM), and is responsible for late-stage clinical development, large outcomes programs, major global filings and health authority interactions (FDA, EMA, Japan, China).Elisabeth’s focus is to get life-changing medications to patients as early as possible to improve their quality and longevity of life.
More episodes of the podcast The Leaders Council Podcast
In Conversation with Sir Andrew Strauss
15/08/2023
In conversation with Sir Geoff Hurst
15/08/2023
In Conversation: Sean Hackemann
15/03/2023
In Conversation: Ben Barnard
10/03/2023
In Conversation: Alex Pearmain
22/02/2023
In Conversation: Paul Armstrong
15/02/2023
In Conversation: Mandana White
08/02/2023
In Conversation: Gabriel Dumaka
03/02/2023
In Conversation: Luke Arnold
01/02/2023
In Conversation: Mike Hicks
27/01/2023
In God we trust